| | | |
|
|
Target Discovery World Congress, South San Francisco, CA, USA
04 August 2009 - 05 August 2009
Target Discovery World Congress will be a meeting focusing on the research looking to find new potential drugs for development. The topics will include presentations on the latest in screening platforms and new methods such as those in High Content and Label-Free Screening and will also focus on the work being done looking for new drug targets in some of the major protein families including Ion Channels, GPCRs, Protein Kinases, Nuclear Receptors and the Ubiquitin Pathway.
|
Molecular Diagnostics World Congress, South San Franscisco, CA, USA
06 August 2009 - 07 August 2009
Welcome to the 2nd Molecular Diagnostics World Congress, this year's event will take place at the South San Francisco Conference Center.
|
| |
|
|
Fabrication and characterization of a fully integrated microdevice for in-vitro single cell assays
(1) FBK-BIOMEMS Unit, via Sommarive 18, 38123 Povo – TN – Italy, (2)Dipartimento di Ingegneria dell’informazione –University of Padova – 35131 Padova – Italy, (3) BioSiLab, 38068 Rovereto – TN – Italy
This work presents the microfabrication and preliminary characterization of a fully integrated microdevice for in-vitro single cell assays. This technological platform combines IDEs and MEA-based modules for cell addressed delivery of bio-functionalized nano/microparticles and single cell electroporation respectively.
|
|
|
|
|
|
|
Multiplexed Diagnostics 2009 Market Report
Published March 2009
Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized.
|
Multiplexed Diagnostics 2008 Market Report
Published May 2008
Multiplexed diagnostics are the wild west of medicine. Technology is established, regulation is limited and the number of new biomarkers exploding. First-movers are grabbing biomarker territories, combining independent measurements for efficiency and mining molecules for multivariate panels. All the while demand is high for improving diagnoses and predicting responses to treatment. The challenges, however, are uncertain reimbursement, unclear business models and ever-intensifying competition. On
|
|
| |
|